| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
AIM ImmunoTech (AMEX:AIM) will release its quarterly earnings report on Tuesday, 2024-04-02. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate AIM ImmunoTech to report an earnings per share (EPS) of $-0.15.
Investors in AIM ImmunoTech are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
In the previous earnings release, the company missed EPS by $0.05, leading to a 3.55% increase in the share price the following trading session.
Here's a look at AIM ImmunoTech's past performance and the resulting price change:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.11 | -0.11 | -0.11 | -0.12 |
| EPS Actual | -0.16 | -0.10 | -0.08 | -0.09 |
| Price Change % | 4.0% | -3.0% | -0.0% | 6.0% |
Shares of AIM ImmunoTech were trading at $0.471 as of March 29. Over the last 52-week period, shares are up 5.57%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for AIM ImmunoTech visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AIM
